HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Makes Preemption Case Once And For All In Final Labeling Rule

Executive Summary

The product liability preemption language in FDA's physician labeling rule applies to all drugs regardless of whether they are regulated by the final rule
Advertisement

Related Content

Pre-emption Rule Delays Safety-related Label Changes, Waxman Charges
Preemption Remains Conference Issue In FDA Bill As Both Sides Declare Victory
Federal Preemption Defense Against Product Liability Weakened In House Bill
FDA Preemption Policy Gets First Appeals Court Test With Zoloft, Paxil Cases
Court Ruling On Preemption Leaves Window Open For False Advertising Suits
Preemption Policy Demands More Meetings With, Documentation From FDA
Boxed Warnings To Be Considered For Drugs With Risk Unique To Class
FDA Chief Counsel Troy Resigns; Agency Says It Will Still Support Preemption
Rx Label Format Changes Should Be Phased In Without "Highlights" - PhRMA
Rx Label Format Changes Should Be Phased In Without "Highlights" - PhRMA
Advertisement
UsernamePublicRestriction

Register

PS046781

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel